MedPath

Fatty Acid Quality and Overweight (FO-study)

Not Applicable
Completed
Conditions
Weight Reduction and Insulin Sensitivity
Registration Number
NCT01034436
Lead Sponsor
Oslo Metropolitan University
Brief Summary

The purpose of this study is to study the health effects of fatty acid quality in healthy, overweight individuals.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
41
Inclusion Criteria
  • no use of medication, healthy, 27<BMI<40
Exclusion Criteria
  • pregnant and lactating women, chronic diseases.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Will intake of fat as diacylglycerols give weight reduction in overweight individuals?baseline (0 weeks), 12 weeks
Secondary Outcome Measures
NameTimeMethod
Will a high intake of ALA involve reduced levels of inflammatory markers?baseline (0 weeks), 12 weeks
Will a high intake of ALA involve changes in insulin sensitivity?baseline (0 weeks), 12 weeks

Trial Locations

Locations (1)

Akershus University College

🇳🇴

Oslo, Lillestrom, Norway

Akershus University College
🇳🇴Oslo, Lillestrom, Norway

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.